Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Immix Biopharma, Inc. (IMMX) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Immix Biopharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1873835.
Total stock buying since 2021: $1,219,587.
Total stock sales since 2021: $550.
Total stock option exercises since 2021: $0.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 4,403 | $10,068 | 0 | $0 | 0 | $0 |
2024 | 62,800 | $132,222 | 0 | $0 | 0 | $0 |
2023 | 201,000 | $654,963 | 0 | $0 | 0 | $0 |
2022 | 0 | $0 | 200 | $550 | 0 | $0 |
2021 | 84,700 | $422,334 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-06 | 4,403 | $10,068 | 0 | $0 | 0 | $0 |
2024-08 | 33,100 | $70,223 | 0 | $0 | 0 | $0 |
2024-07 | 9,200 | $19,516 | 0 | $0 | 0 | $0 |
2024-06 | 11,700 | $22,777 | 0 | $0 | 0 | $0 |
2024-05 | 8,800 | $19,706 | 0 | $0 | 0 | $0 |
2023-12 | 56,000 | $266,919 | 0 | $0 | 0 | $0 |
2023-09 | 144,000 | $386,035 | 0 | $0 | 0 | $0 |
2023-08 | 1,000 | $2,009 | 0 | $0 | 0 | $0 |
2022-07 | 0 | $0 | 200 | $550 | 0 | $0 |
2021-12 | 84,700 | $422,334 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-06-18 | Morris Gabriel S (CFO) | Buy | 2,225 | 2.28 | 5,070 |
2025-06-18 | Rachman Ilya M (CEO and Chairman) | Buy | 2,178 | 2.29 | 4,998 |
2024-08-22 | Hsu Jason | Buy | 8,100 | 2.25 | 18,233 |
2024-08-21 | Hsu Jason | Buy | 15,000 | 2.23 | 33,390 |
2024-08-16 | Ng Carey | Buy | 10,000 | 1.86 | 18,600 |
2024-07-24 | Hsu Jason | Buy | 6,000 | 2.15 | 12,876 |
2024-07-18 | Hsu Jason | Buy | 3,200 | 2.08 | 6,640 |
2024-06-07 | Morris Gabriel S (CFO) | Buy | 2,500 | 2.12 | 5,297 |
2024-06-07 | Rachman Ilya M (CEO and Chairman) | Buy | 2,600 | 2.13 | 5,538 |
2024-06-04 | Morris Gabriel S (CFO) | Buy | 3,300 | 1.81 | 5,973 |
2024-06-04 | Rachman Ilya M (CEO and Chairman) | Buy | 3,300 | 1.81 | 5,969 |
2024-05-14 | Morris Gabriel S (CFO) | Buy | 4,500 | 2.23 | 10,044 |
2024-05-14 | Rachman Ilya M (CEO and Chairman) | Buy | 4,300 | 2.25 | 9,662 |
2023-12-11 | Hsu Jason | Buy | 31,000 | 4.67 | 144,894 |
2023-12-08 | Hsu Jason | Buy | 25,000 | 4.88 | 122,025 |
2023-09-15 | Hsu Jason | Buy | 7,000 | 2.48 | 17,395 |
2023-09-14 | Hsu Jason | Buy | 10,000 | 2.58 | 25,770 |
2023-09-14 | Ng Carey | Buy | 10,000 | 2.58 | 25,760 |
2023-09-12 | Hsu Jason | Buy | 30,000 | 2.83 | 84,870 |
2023-09-12 | Adams Helen C. | Buy | 13,000 | 2.96 | 38,493 |
2023-09-11 | Hsu Jason | Buy | 25,000 | 2.89 | 72,275 |
2023-09-08 | Hsu Jason | Buy | 10,000 | 2.53 | 25,320 |
2023-09-07 | Buchan Melissa Jane | Buy | 20,000 | 2.46 | 49,220 |
2023-09-06 | Marquet Magda | Buy | 9,000 | 2.47 | 22,212 |
2023-09-05 | Marquet Magda | Buy | 10,000 | 2.47 | 24,720 |
2023-08-31 | Marquet Magda | Buy | 1,000 | 2.01 | 2,009 |
2022-07-14 | Senn Sean | Sale | 200 | 2.75 | 550 |
2021-12-20 | Hsu Jason | Buy | 50,000 | 5.00 | 250,000 |
2021-12-20 | Morris Gabriel S (Chief Financial Officer) | Buy | 2,000 | 5.00 | 10,000 |
2021-12-20 | Torchilin Vladimir P (Scientific Co-Founder) | Buy | 3,000 | 5.00 | 15,000 |
2021-12-20 | Ng Carey | Buy | 25,000 | 5.00 | 125,000 |
2021-12-20 | Rachman Ilya M (CEO and Chairman) | Buy | 2,500 | 5.00 | 12,500 |
2021-12-17 | Torchilin Vladimir P (Scientific Co-Founder) | Buy | 2,200 | 4.47 | 9,834 |
Insider trading activities including stock purchases, stock sales, and option exercises of IMMX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Immix Biopharma, Inc. (symbol IMMX, CIK number 1873835) see the Securities and Exchange Commission (SEC) website.